Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000351593

Medchemexpress LLC Rezvilutamide (SHR3680) | 1572045-62-5 | 99.8% | 479.47 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY13744850MG

Encompass_Preferred

Rezvilutamide (SHR3680) is an orally active androgen receptor antagonist used for the study of prostate cancer. It inhibits the nuclear translocation, transcriptional activity, overexpression, and secretion of prostate-specific antigen of androgen receptor in prostate cancer cells, and exhibits an inducing effect on CYP3A4 and CYP2B6.

  • Inhibits nuclear translocation and transcriptional activity
  • Reduces overexpression and secretion of prostate-specific antigen in prostate cancer cells
  • Induces CYP3A4 and CYP2B6

Catalog No. 50-003-51593


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.